These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15665794)
1. Safety and efficacy of drug-eluting stents. Williams DO; Kereiakes DJ Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794 [TBL] [Abstract][Full Text] [Related]
2. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063 [TBL] [Abstract][Full Text] [Related]
3. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. Perin EC Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793 [TBL] [Abstract][Full Text] [Related]
4. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions. Ray GM; Nawarskas JJ; Frishman WH Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial versus registry data--comparing apples and ORCHIDs. Moliterno DJ Catheter Cardiovasc Interv; 2006 Nov; 68(5):669-70. PubMed ID: 17039505 [No Abstract] [Full Text] [Related]
6. Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians. Vijayakumar M; Lemos PA; Hoye A; Ong AT; Aoki J; Granillo GR; McFadden EP; Sianos G; Hofma SH; Smits PC; van der Giessen WJ; de Feyter P; van Domburg RT; Cummins PA; Serruys PW Am J Cardiol; 2004 Oct; 94(7):909-13. PubMed ID: 15464675 [TBL] [Abstract][Full Text] [Related]
7. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A; J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents. Kereiakes DJ; Young JJ Rev Cardiovasc Med; 2005; 6 Suppl 1():S48-58. PubMed ID: 15665798 [TBL] [Abstract][Full Text] [Related]
10. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis. Mahmud E; Bromberg-Marin G; Palakodeti V; Ang L; Creanga D; Demaria AN J Am Coll Cardiol; 2008 Jun; 51(25):2385-95. PubMed ID: 18565394 [TBL] [Abstract][Full Text] [Related]
12. Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Chu WW; Kuchulakanti PK; Torguson R; Wang B; Clavijo LC; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R Catheter Cardiovasc Interv; 2006 Jul; 68(1):62-6. PubMed ID: 16755592 [TBL] [Abstract][Full Text] [Related]
13. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease. Kornowski R; Vaknin-Assa H; Assali A; Fuchs S Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions. Aziz S; Ramsdale DR J Invasive Cardiol; 2005 Jan; 17(1):13. PubMed ID: 15640532 [No Abstract] [Full Text] [Related]
15. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus. Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468 [TBL] [Abstract][Full Text] [Related]
16. The approach to small vessels in the era of drug-eluting stents. Holmes DR; Kereiakes DJ Rev Cardiovasc Med; 2005; 6 Suppl 1():S31-7. PubMed ID: 15665796 [TBL] [Abstract][Full Text] [Related]
17. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. Moreno R; Fernández C; Hernández R; Alfonso F; Angiolillo DJ; Sabaté M; Escaned J; Bañuelos C; Fernández-Ortiz A; Macaya C J Am Coll Cardiol; 2005 Mar; 45(6):954-9. PubMed ID: 15766835 [TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. Schömig A; Dibra A; Windecker S; Mehilli J; Suárez de Lezo J; Kaiser C; Park SJ; Goy JJ; Lee JH; Di Lorenzo E; Wu J; Jüni P; Pfisterer ME; Meier B; Kastrati A J Am Coll Cardiol; 2007 Oct; 50(14):1373-80. PubMed ID: 17903638 [TBL] [Abstract][Full Text] [Related]